Диссертация (1140198), страница 17
Текст из файла (страница 17)
B. Postuma // Neurology. – 2009. – Vol. 72, № 11.– P. 955–960.85.Högl, B. Therapeutic advances in restless legs syndrome / B. Högl,C. Comella // Mov. Disord. – 2015. – Vol. 30, № 11. – P. 1574–1579.86.Horvath, J. Restless arms / J. Horvath, T. Landis, P. R. Burkhard // TheLancet. – 2008. – Vol. 371, № 9611. – P.
530.87.Iannaccone, S. Evidence of peripheral anonal neuropathy in primary restlesslegs syndrome / S. Iannaccone, M. Zucconi, P. Marchellini // Movem. Dis. – 1995. –98Vol.10, № 1. – P. 1–9.88.Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primarycare population: the REST (RLS epidemiology, symptoms, and treatment) primary carestudy / W. Hening [et al.] // Sleep Med. – 2004. – Vol. 5, № 3. –P. 237–246.89.Impulse control disorders with the use of dopaminergic agents in restless legssyndrome: a case-control study / J. R. Cornelius [et al.] // Sleep. – 2010.
– № 33. – P. 81–87.90.Inoue, Y. Diagnosis and symptom rating scale of restless legs syndrome / Y.Inoue // Brain Nerve. – 2009. – Vol. 61, № 5. –P. 533–538.91.Insomnia and daytime sleepiness are risk factors for depressive symptoms inthe elderly / I. Jaussent [et al.] // Sleep. – 2011. – Vol. 34, № 8. – P. 1103–1110.92.International Restless Legs Syndrome Study Group. Restless legssyndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless LegsSyndrome Study Group (IRLSSG) consensus criteria-history, rationale, description, andsignificance / R.
P. Allen [et al.] // Sleep Med. – 2014. – № 15. – P. 860–873.93.Jamal, G. A. The neurophysiologic investigation of small fiber neuropathies/ G. A. Jamal, S. Hansen, A. I. Weir // Muscle Nerve. – 1987. – Vol. 10, № 6. – P. 537–545.94.Jørgensen, S. Restless Legs Syndrome / S. Jørgensen, S. Rønborg //Ugeskrift for Læger. – 1989. – Vol. 151, № 11.
– P. 670–671.95.Kaplan, P. W. A double-blind, placebo-controlled study of the treatment ofperiodic limb movements in sleep using carbidopa/levodopa and propoxyphene /P. W. Kaplan, R. P. Allen, D. W. Buchholz, J. K. Walters // Sleep. – 1993. – Vol. 16,№ 8. – P. 717–723.96.Koo, B. B.
Restless Legs Syndrome: Current Concepts about DiseasePathophysiology / B. B. Koo, K. Bagai, A. S. Walters // Tremor Other Hyperkinet Mov.– 2016. – Vol. 6. – P. 401.97.Lauerma, H. Treatment of restless legs syndrome with tramadol: an openstudy / H. Lauerma, J. Markkula // J. Clin. Psychiatry.
– 1999. – Vol. 60, № 4. –99P. 241–244.98.Lawrence, A. D. Selective disruption of the recognition of facial expressionof anger / A. D. Lawrence, A. J. Calder, S. W. McGowan, P. M. Grasby // Neuroreport.– 2002. – Vol. 13, № 6. – P. 881–884.99.Levodopa for the treatment of restless legs syndrome [Электронныйресурс]/ H. Scholz [et al.] // Cochrane library – 2011. – Режимдоступа: (датаобращения 31.03. 2017).100. Lo Coco, D.
Restless legs syndrome in a patient with multifocal motorneuropathy / D. Lo Coco, E. Cannizzaro, G. Lopez // Neurol. Sci. –2009. – Vol. 30, № 5.– P. 401–403.101. Long-term follow-up on restless legs syndrome patients treated with opioids/ A. S. Walters [et al.] // Mov.
Disord. – 2001. – Vol. 16, №6. – P. 1105–1109.102. Long-term open-label study of pramipexole in patients with primary restlesslegs syndrome / Y. Inoue [et al.] // J. Neurol. Sci. – 2010. – Vol. 294, №1-2. – P. 62–66.103. Matthews, W. B. Treatment of the restless legs syndrome with clonazepam/ W. B Matthews // Br Med J. – 1979. – Vol. 1. – P. 751.104. Mirapexsideeffects[Электронныйресурс].–Режимдоступа:https://www.drugs.com/pro/mirapex.html#s5.7 (дата обращения 29.
05. 2017).105. Möller, C. Differential diagnosis of unpleasant sensations in the legs:prevalence of restless legs syndrome in a primary care population / C. Möller,T. C. J. Wetter, K. Stiasny-Kolster // Sleep Med. – 2010. – Vol. 11, № 2. – P. 161–166.106. Molnar, M. Z. Association of incident restless legs syndrome with outcomesin a large cohort of US veterans /. M. Z. Molnar, J. L.
Lu, K. Kalantar-Zadeh.,C. P. Kovesdy // J Sleep Res. – 2016. – Vol. 25, № 1. – P. 47–56.107. Montplaisir, J. Familial restless legs with periodic movements in sleep:electrophysiologic, biochemical, and pharmacologic study / J. Montplaisir, R. Godbout,D. Boghen // Neurology. – 1985. – Vol. 35, № 1. – P. 130–134.108. Mühlau, G. Six months’ treatment of restless legs syndrome withlevodopa/benserazide in domiciliary practice / G. Mühlau // MMW Fortschr.
Med. –2004. –Vol. 146, № 3. – P. 87–93.100109. Muller, U. Levodopa dependency in Parkinson’s disease: case report andreview / U. Muller, M. Reuter, W. Hermann // Nervenarzt. – 2002. – Vol. 73, № 9. –P. 887–891.110. O’Keeffe, S.T. Restless legs syndrome: a review / S.T. O’Keeffe // Arch.Intern. Med. – 1996. –Vol. 156, № 20. – P. 243–248.111. O’Sullivan, S. S. Dopamine Dysregulation syndrome: an overview of itsepidemiology, mechanism and management / S. S.
O’Sullivan, A. H. Evans, A. J. Lees //CNS Drugs. – 2009. – Vol. 23, № 2. – P. 157–170.112. Ondo, W. G. Association between restless legs syndrome and essentialtremor / W. G. Ondo, D. Lai // Mov. Disord. – 2006. – Vol. 21, № 4.– P. 515–518.113. Ondo, W. G. Exploring the relationship between Parkinson disease andrestless legs syndrome / W. G. Ondo, K. D. Vuong, J. Jankovic // Arch. Neurol. – 2002.–Vol.
–59, № 3. – P. 421–424.114. Ondo, W. G. Methadone for refractory restless legs syndrome / W. G. Ondo// Mov. Disord. – 2005. – Vol. 20, № 3. – P. 345–348.115. Ondo, W. G. Restless legs syndrome: clinicoetiologic correlates / W. Ondo,J. Jankovic // Neurology. – 1996.
– Vol. 47. – P. 1435–1441.116. One-year treatment with standard and sustained-release levodopa:Appropriate long-term treatment of restless legs syndrome? / C. Trenkwalder [et al.] //Mov. Disord. – 2003. – Vol. 18, № 10. – P. 1184–1189.117. Open-label study of the long-term efficacy and safety of pramipexole inpatients with Restless Legs Syndrome (extension of the PRELUDE study) / M.
Partinen[et al.] // Sleep Med. – 2008. – Vol. 9, № 5. – P. 537–541.118. Opioidsforrestlesslegssyndrome[Электронныйресурс]/C. O. de Oliveira [et al.] // Cochrane Database Syst. Rev. – 2016. – Режим доступа:https://www.ncbi.nlm.nih.gov/pubmed/27355187 (дата обращения 27. 03. 2017).119. Paulus, W.Pathophysiologyofdopaminergictherapy–relatedaugmentationin restless legs syndrome / W. Paulus, С. Trenkwalder // Lancet Neurology.– 2006.
– Vol. 5. – P. 878–886.120. Pelletier, G., Sensory and motor components of the restless legs syndrome /101G. Pelletier, D. Lorrain, J. Montplaisir // Neurology. – 1992. – Vol. 42, № 9. –P. 1663–1666.121. Perez-Dıaz, H. Restless abdomen: a phenotypic variant of restless legssyndrome / H. Perez-Dıaz, A. Iranzo, D. B. Rye // Neurology.
– 2011. – Vol. 77, № 13.– P. 1283–1286.122. Picchietti, D. Restless legs syndrome, periodic limb movements in sleep, anddepression / D. Picchietti, J. W. Winkelman // Sleep. – 2005. – Vol. 28, № 7. – P. 891–898.123. Positron emission tomographic studies in restless legs syndrome /C. Trenkwalder [et al.] // Mov. Disord. – 1999. – Vol.
14, №1. – P. 141–145.124. Practice guideline summary: Treatment of restless legs syndrome in adults /J. W. Winkelman [et al.] // Neurology. – 2016. – Vol. 87, № 24. – P. 2585–2589.125. Prevalence and disease burden of primary restless legs syndrome: results ofa generalpopulation survey in the United States / R. P.
Allen [et al.] //Mov. Disord. –2011. – Vol. 26, №1. – P. 114–120.126. Prevalence and risk factors of RLS in an elderly population: the MEMOstudy. Memory and Morbidity in Augsburg Elderly / A. J. Rothdach [et al.] // Neurology.– 2000. – Vol. 54, № 5. – P. 1064–1068.127. Prevalence, severity and risk factors of restless legs syndrome in the generaladult population in two Scandinavian countries / B.
Bjorvatn [et al.] // Sleep Med. – 2005.– Vol. 6, № 4. – P. 307–312.128. Prevalences of periodic limb movement–like and restless legs-likesymptoms among Japanese adults / T. Kageyama [et al.] // Psychiatry Clin. Neurosci. –2000. – Vol. 54, № 3. – P.
296–298.129. Prolonged release oxycodone-naloxone for treatment of severe restless legssyndrome after failure of previous treatment: a double-blind, randomised, placebocontrolled trial with an open-label extension \ C. Trenkwalder [et al.] \\ Lancet Neurol. –2013. – Vol.
12, № 12. – P. 1141–1150.130. Prospective evaluation of somatic and autonomic small fibers in selectedautonomic neuropathies / W. Singer [et al.] // Neurology. – 2004. – Vol. 62, № 4. –102P. 612–618.131. Prospective study of restless legs syndrome and coronary heart diseaseamong women / Y.
Li [et al.] // Circulation. – 2012. – Vol. 126, № 14. – P. 1689–1694.132. Prospective study of Restless Legs Syndrome and risk of depression inwomen / Y. Li [et al.] // Am J Epidemiol. – 2012 Vol. 176, № 4. – P. 279-288.133. Rajabally, Y. A. Restless legs syndrome in chronic inflammatorydemyelinating polyneuropathy / Y.A. Rajabally, R. S. Shah // Muscle Nerve.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
